肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

非整倍体作为恶性生长的启动子和抑制子

Aneuploidy as a promoter and suppressor of malignant growth

原文发布日期:2021-01-11

DOI: 10.1038/s41568-020-00321-1

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

非整倍体作为恶性生长的启动子和抑制子

Aneuploidy as a promoter and suppressor of malignant growth

原文发布日期:2021-01-11

DOI: 10.1038/s41568-020-00321-1

类型: Review Article

开放获取: 否

 

英文摘要:

Aneuploidy has been recognized as a hallmark of tumorigenesis for more than 100 years, but the connection between chromosomal errors and malignant growth has remained obscure. New evidence emerging from both basic and clinical research has illuminated a complicated relationship: despite its frequency in human tumours, aneuploidy is not a universal driver of cancer development and instead can exert substantial tumour-suppressive effects. The specific consequences of aneuploidy are highly context dependent and are influenced by a cell’s genetic and environmental milieu. In this Review, we discuss the diverse facets of cancer biology that are shaped by aneuploidy, including metastasis, drug resistance and immune recognition, and we highlight aneuploidy’s distinct roles as both a tumour promoter and an anticancer vulnerability.

 

摘要翻译: 

非整倍体在一百多年前就被确认为肿瘤发生的标志之一,但染色体错误与恶性生长之间的关联始终未明。基础与临床研究的新证据揭示了这一复杂关系:尽管非整倍体在人类肿瘤中普遍存在,它并非癌症发展的必然驱动因素,反而可能产生显著的肿瘤抑制效应。非整倍体的具体后果高度依赖环境背景,并受细胞遗传特性和微环境的影响。本文综述中,我们将探讨非整倍体塑造癌症生物学的多个维度——包括转移、耐药性和免疫识别,并重点阐释非整倍体作为肿瘤促进因子与抗癌弱点的双重角色。

 

原文链接:

Aneuploidy as a promoter and suppressor of malignant growth

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……